Seer (SEER) Cash from Operations (2020 - 2026)
Seer (SEER) posted quarterly Cash from Operations of 15435000.0 for Q1 2026, down 35.19% year-over-year from 23816920.53 in Q1 2025, and down 42.82% quarter-over-quarter from 10807000.0 in Q4 2025.
Seer (SEER) Cash from Operations (2020 - 2026) Analysis & Trends
Seer's Cash from Operations history runs 7 years deep, the most recent figure standing at 15435000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 35.19% year-over-year to 15435000.0; the TTM figure through Mar 2026 stood at 48466000.0 (down 2.97% YoY), while the FY2025 annual figure was 44448000.0, up 3.6% from the prior year.
- Cash from Operations for Q1 2026 stood at 15435000.0, down from 10807000.0 in the prior quarter.
- The five-year high for Cash from Operations was 7566000.0 in Q3 2025, with the low at 19331000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 14000000.0 (2022), against an average of 13284529.41.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 52.73% in 2022, then surged 46.44% in 2025.
- Seer's Cash from Operations stood at 14256000.0 in 2022, then rose by 28.52% to 10190000.0 in 2023, then decreased by 12.43% to 11457000.0 in 2024, then grew by 5.67% to 10807000.0 in 2025, then sank by 42.82% to 15435000.0 in 2026.
- Business Quant data shows SEER's Cash from Operations at 15435000.0 in Q1 2026, 10807000.0 in Q4 2025, and 7566000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -9.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.57 Mn |
| Jun 30, 2026 | -9.57 Mn |
| Mar 31, 2026 | -15.44 Mn |
| Mar 31, 2026 | -15.44 Mn |
| Dec 31, 2025 | -10.81 Mn |
| Dec 31, 2025 | -10.81 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Jun 30, 2025 | -14.66 Mn |
| Jun 30, 2025 | -14.66 Mn |
| Mar 31, 2025 | -11.42 Mn |
| Mar 31, 2025 | -11.42 Mn |
| Dec 31, 2024 | -11.46 Mn |
| Dec 31, 2024 | -11.46 Mn |
| Sep 30, 2024 | -14.13 Mn |
| Sep 30, 2024 | -14.13 Mn |
| Jun 30, 2024 | -10.07 Mn |
| Jun 30, 2024 | -10.07 Mn |
| Mar 31, 2024 | -10.46 Mn |
| Mar 31, 2024 | -10.46 Mn |